Rationale for In-Neonatal Intensive Care Unit Administration of Live, Attenuated Rotavirus Vaccination

Courtney Briggs-Steinberg; Shetal Shah

doi:10.1055/s-0038-1660463

American Journal of Perinatology, Table of Contents

Am J Perinatol 2018; 35(14): 1443-1448
DOI: 10.1055/s-0038-1660463

Commentary

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Rationale for In-Neonatal Intensive Care Unit Administration of Live, Attenuated Rotavirus Vaccination

Courtney Briggs-Steinberg

¹Division of Newborn Medicine, Maria Fareri Children's Hospital, Valhalla, New York

,

Shetal Shah

¹Division of Newborn Medicine, Maria Fareri Children's Hospital, Valhalla, New York

› Author Affiliations

Abstract

Rotavirus is the most common nonseasonal vaccine preventable illness. Despite increased severity of rotaviral illness in early infancy, most neonatal intensive care units (NICU) do not administer rotavirus vaccination either during the NICU stay at age of eligibility or at discharge as the Advisory Committee on Immunization Practices recommends. In this commentary, we review the rationale for the administration of rotavirus vaccination to premature infants. Further, we outline data supporting vaccine administration at chronologic age while still admitted to the NICU.

Keywords

rotavirus - immunization - NICU - premature infants

Full Text

References

References
1 Dennehy PH. Rotavirus vaccines--an update. Vaccine 2007; 25 (16) 3137-3141
2 Payne DC, Staat MA, Edwards KM. , et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics 2008; 122 (06) 1235-1243
3 Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 2007; 119 (04) 684-697
4 Cortes JE, Curns AT, Tate JE. , et al. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med 2011; 365 (12) 1108-1117
5 Clark HF, Marcello AE, Lawley D, Reilly M, DiNubile MJ. Unexpectedly high burden of rotavirus gastroenteritis in very young infants. BMC Pediatr 2010; 10 (40) 40
6 Zhou F, Shefer A, Wenger J. , et al. Economic evaluation of the routine childhood immunization program in the United States, 2009. Pediatrics 2014; 133 (04) 577-585
7 Leshem E, Tate JE, Steiner CA, Curns AT, Lopman BA, Parashar UD. National estimates of reductions in acute gastroenteritis-related hospitalizations and associated costs in US children after implementation of rotavirus vaccines. J Pediatric Infect Dis Soc 2017; 35 (14) 1-4
8 Crawford SE, Ramani S, Tate JE. , et al. Rotavirus infection. Nat Rev Dis Primers 2017; 3: 17083
9 Roué J-M, Nowak E, Le Gal G. , et al. Impact of rotavirus vaccine on premature infants. Clin Vaccine Immunol 2014; 21 (10) 1404-1409
10 Dennehy PH, Cortese MM, Bégué RE. , et al. A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children. Pediatr Infect Dis J 2006; 25 (12) 1123-1131
11 Goveia MG, Rodriguez ZM, Dallas MJ. , et al; REST Study Team. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J 2007; 26 (12) 1099-1104
12 Newman RD, Grupp-Phelan J, Shay DK, Davis RL. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics 1999; 103 (01) E3
13 Bresee JS, Glass RI, Ivanoff B, Gentsch JR. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 1999; 17 (18) 2207-2222
14 Sharma R, Hudak ML, Premachandra BR. , et al. Clinical manifestations of rotavirus infection in the neonatal intensive care unit. Pediatr Infect Dis J 2002; 21 (12) 1099-1105
15 Shim JO, Son DW, Shim SY, Ryoo E, Kim W, Jung YC. Clinical characteristics and genotypes of rotaviruses in a neonatal intensive care unit. Pediatr Neonatol 2012; 53 (01) 18-23
16 Rotbart HA, Levin MJ, Yolken RH, Manchester DK, Jantzen J. An outbreak of rotavirus-associated neonatal necrotizing enterocolitis. J Pediatr 1983; 103 (03) 454-459
17 Rotbart HA, Nelson WL, Glode MP. , et al. Neonatal rotavirus-associated necrotizing enterocolitis: case control study and prospective surveillance during an outbreak. J Pediatr 1988; 112 (01) 87-93
18 Linhares AC, Mascarenhas JD, Gusmão RH, Gabbay YB, Fialho AM, Leite JP. Neonatal rotavirus infection in Belém, northern Brazil: nosocomial transmission of a P[6] G2 strain. J Med Virol 2002; 67 (03) 418-426
19 Committee on Infectious Diseases; American Academy of Pediatrics. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics 2009; 123 (05) 1412-1420
20 Cortese MM, Parashar UD. ; Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009; 58 (RR-2): 1-25
21 Rha B, Tate JE, Weintraub E. , et al. Intussusception following rotavirus vaccination: an updated review of the available evidence. Expert Rev Vaccines 2014; 13 (11) 1339-1348
22 Shui IM, Baggs J, Patel M. , et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA 2012; 307 (06) 598-604
23 Rotarix, rotavirus vaccine, live, oral [package insert]. Oral suspension, initial US approval; 2008. Available at: https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/ Prescribing_Information/Rotarix/pdf/ROTARIX-PI-PIL.PDF . Accessed January 12, 2018
24 Shah S. Immunization issues in preterm infants: pertussis, influenza, rotavirus. Neoreviews 2014; 15 (10) e439-e446
25 Hofstetter AM, Lacombe K, Klein EJ. , et al. Risk of rotavirus nosocomial spread after inpatient pentavalent rotavirus vaccination. Pediatrics 2018; 141 (01) e20171110
26 Stumpf KA, Thompson T, Sánchez PJ. Rotavirus vaccination of very low birth weight infants at discharge from the NICU. Pediatrics 2013; 132 (03) e662-e665
27 Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR. , et al; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354 (01) 11-22
28 Vesikari T, Matson DO, Dennehy P. , et al; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354 (01) 23-33
29 Omenaca F, Sarlangue J, Szenborn L. , et al; ROTA-054 Study Group. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study. Pediatr Infect Dis J 2012; 31 (05) 487-493
30 Smith CK, McNeal MM, Meyer NR, Haase S, Dekker CL. Rotavirus shedding in premature infants following first immunization. Vaccine 2011; 29 (45) 8141-8146
31 Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis 2008; 8 (10) 642-649
32 Clark HF, Bernstein DI, Dennehy PH. , et al. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr 2004; 144 (02) 184-190
33 Monk HM, Motsney AJ, Wade KC. Safety of rotavirus vaccine in the NICU. Pediatrics 2014; 133 (06) e1555-e1560
34 Nallu LA, Ehrenkranz R, Vazquez M. Impact of length of neonatal intensive care unit hospitalization on receipt of rotavirus vaccine. Poster presented at Annual Meeting of the Pediatric Academic Society; Apr 30-May 03, 2016; Baltimore, MD. Abstract 1521.586
35 Fang AY, Tingay DG. Early observations in the use of oral rotavirus vaccination in infants with functional short gut syndrome. J Paediatr Child Health 2012; 48 (06) 512-516
36 Javid PJ, Sanchez SE, Jacob S, McNeal MM, Horslen SP, Englund JA. The safety and immunogenicity of rotavirus vaccination in infants with intestinal failure. J Pediatric Infect Dis Soc 2014; 3 (01) 57-65
37 Hiramatsu H, Suzuki R, Nagatani A. , et al. Rotavirus vaccination can be performed without viral dissemination in the Neonatal Intensive Care Unit. J Infect Dis 2018; 217 (04) 589-596
38 National Center for Health Statistics. final natality data. Available at: www.marchofdimes.org/peristats . Accessed June 7th, 2017
39 Skowronski DM, Janjua NZ, Tsafack EP, Ouakki M, Hoang L, De Serres G. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis 2012; 54 (03) 318-327
40 Saari TN. ; American Academy of Pediatrics Committee on Infectious Diseases. Immunization of preterm and low birth weight infants. Pediatrics 2003; 112 (1 Pt 1): 193-198
41 Jaques SC, Ogley L, Duffy D, Kennea N. Rotavirus immunisation in NICU: a 1-year experience in a UK tertiary neonatal surgical unit postvaccine introduction. Arch Dis Child Fetal Neonatal Ed 2015; 100 (02) F186-F187
42 Kilich E, Anthony M. Rotavirus vaccination in preterm infants: a neonatal guidance chart to aid timely immunisation. Arch Dis Child Fetal Neonatal Ed 2015; 100 (05) F465
43 Thrall S, Doll MK, Nhan C. , et al. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units. Vaccine 2015; 33 (39) 5095-5102